Dietary Supplements

Development
Launch
Marketing

ZanthoSyn®

Astaxanthin Supplement for Inflammatory Health*

Commercially Available Dietary Supplement

85%

Pharmaceutical Candidates

Discovery
Preclinical
Clinical

CDX-101

Astaxanthin Rx Candidate for Cardiovascular Inflammation and Dyslipidemia

Preclinical

50%

CDX-301

Zeaxanthin Rx Candidate for Macular Degeneration

Preclinical

43%